S&B PHARMA LLC
Limited Liability Company · WILMINGTON, United States · LEI 984500B0F30P70443993
LEI lapsed
Summary
S&B PHARMA LLC is registered in the United States. Its legal form is Limited Liability Company. According to GLEIF, its ultimate parent is ALKEM LABORATORIES LIMITED (India), which is also its direct parent. That group has 8 subsidiaries with LEIs in 4 countries, 3 of them in the United States. The LEI was first issued on 23 Nov 2022 and the record was last updated on 25 Nov 2025. It has lapsed: renewal was due by 25 Nov 2025. AssetCensus found 3 data-quality notes for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 25 Nov 2025 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
- The ultimate-parent link rests on accounts for the period ending 31 Mar 2023, more than 24 months before this data release. The group may have changed since.
- The ultimate-parent relationship record was not renewed; it was last updated on 25 Nov 2025.
Company details
| Legal form | Limited Liability Company |
|---|---|
| Register | · Register website |
| Registration number | 7928289 |
| Registration authority | Division of Corporations, Department of State |
| Jurisdiction | United States (US-DE) |
| Registered address | CORPORATION TRUST CENTER 1209 ORANGE ST, 19801 WILMINGTON, United States |
| Headquarters address | 405 SOUTH MOTOR AVENUE, 91702 AZUSA, United States |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 8 Apr 2020 |
| LEI | 984500B0F30P70443993 |
| LEI status | lapsed |
| LEI first issued | 23 Nov 2022 |
| LEI record last updated | 25 Nov 2025 |
| Next LEI renewal | 25 Nov 2025 |
| Corroboration of the LEI record | fully corroborated |
Group membership
S&B PHARMA LLC this entity
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | ALKEM LABORATORIES LIMITED | ALKEM LABORATORIES LIMITED |
| Accounting period | 31 Mar 2022 to 31 Mar 2023 | 31 Mar 2022 to 31 Mar 2023 |
| Evidence | consolidated accounts | consolidated accounts |
| Corroboration | supplied by the entity only | supplied by the entity only |
| Accounting standard | IFRS | IFRS |
| Consolidation percentage reported to GLEIF | 100.00% | 100.00% |
| Relationship start | 8 Apr 2020 | 8 Apr 2020 |
| Recorded at GLEIF since | 23 Nov 2022 | 23 Nov 2022 |
| Last updated | 25 Nov 2025 | 25 Nov 2025 |
| Record status | not renewed | not renewed |
Other subsidiaries of the same direct parent (7)
- ASCEND LABORATORIES, LLC United States lapsed
- THE PHARMA NETWORK, LLC United States lapsed
- ADROIT BIOMED LIMITED India
- ASCEND LABORATORIES SPA Chile lapsed
- ENZENE BIOSCIENCES LIMITED India
- INDCHEMIE HEALTH SPECIALITIES PRIVATE LIMITED India
- Товарищество с ограниченной ответственностью "The Pharmа Network" Kazakhstan lapsed